Evidence map›Paper›PMID 19805546›Full record

ArticleThe Journal of biological chemistry2009

Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor.

Liang Lu, Shuying Wang, Lei Zheng, Xuelin Li, Esther A Suswam, Xiaowen Zhang, Crystal G Wheeler, L B Nabors, Natalia Filippova, Peter H King

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Targets and Gene Therapy of ALS (Part 1).International journal of molecular sciences · 2025
    Review
  5. Review
  6. Review
  7. The long noncoding RNAScience advances · 2022
    Article
  8. T-Cell Intracellular Antigen 1-Like Protein in Physiology and Pathology.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Neuron-Specific HuR-Deficient Mice Spontaneously Develop Motor Neuron Disease.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Liang LuDepartment of Neurology, University of Alabama at Birmingham and the Birmingham Veterans Affairs Medical Center, Birmingham, Alabama 35294, USA.
Shuying Wang
Lei Zheng
Xuelin Li
Esther A Suswam
Xiaowen Zhang
Crystal G Wheeler
L B Nabors
Natalia Filippova
Peter H King
Birmingham VA Medical Center · US

Funding

Training Program in Brain Tumor BiologyT32NS048039 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BENVENISTE, ETTY N · 2007 to 2017
$2.0M
The Role of HuR in mutant SOD1 dysregulation of VEGF mRNA ProcessingR01NS064133 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KING, PETER H · 2008 to 2011
$1.2M
Post-transcriptional Regulation Requires Phosphorylation of HuR in GliomaR01CA112397 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NABORS, LOUIS B · 2006 to 2009
$910k
Dysregulation of VEGF RNA Stability in Amyotrophic Lateral SclerosisK08NS057664 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LU, LIANG · 2008 to 2012
$729k
Aberrant VEGF RNA Stability in Amyotrophic Lateral SclerosisR21NS058538 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KING, PETER H · 2007 to 2008
$349k
HuR regulates TDP-43 and FUS: implications for ALS pathogenesisI01BX003035 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI LU, LIANG · 2016 to 2021
–
BLRD VA I01 BX003035NCI NIH HHS R01 CA112397NINDS NIH HHS K08 NS057664NINDS NIH HHS NS057664NINDS NIH HHS NS058538NINDS NIH HHS NS064133NINDS NIH HHS R01 NS064133NINDS NIH HHS R21 NS058538NINDS NIH HHS T32 NS048039
6 · The paper itself

Abstract

Down-regulation of vascular endothelial growth factor (VEGF) in the mouse leads to progressive and selective degeneration of motor neurons similar to amyotrophic lateral sclerosis (ALS). In mice expressing ALS-associated mutant superoxide dismutase 1 (SOD1), VEGF mRNA expression in the spinal cord declines significantly prior to the onset of clinical manifestations. In vitro models suggest that dysregulation of VEGF mRNA stability contributes to that decline. Here, we show that the major RNA stabilizer, Hu Antigen R (HuR), and TIA-1-related protein (TIAR) colocalize with mutant SOD1 in mouse spinal cord extracts and cultured glioma cells. The colocalization was markedly reduced or abolished by RNase treatment. Immunoanalysis of transfected cells indicated that colocalization occurred in insoluble aggregates and inclusions. RNA immunoprecipitation showed a significant loss of VEGF mRNA binding to HuR and TIAR in mutant SOD1 cells, and there was marked depletion of HuR from polysomes. Ectopic expression of HuR in mutant SOD1 cells more than doubled the mRNA half-life of VEGF and significantly increased expression to that of wild-type SOD1 control. Cellular effects produced by mutant SOD1, including impaired mitochondrial function and oxidative stress-induced apoptosis, were reversed by HuR in a gene dose-dependent pattern. In summary, our findings indicate that mutant SOD1 impairs post-transcriptional regulation by sequestering key regulatory RNA-binding proteins. The rescue effect of HuR suggests that this impairment, whether related to VEGF or other potential mRNA targets, contributes to cytotoxicity in ALS.

Indexed as

MutationAmyotrophic Lateral SclerosisAnimalsAntigens, SurfaceCytoplasmELAV-Like Protein 1ELAV ProteinsMiceModels, BiologicalNeuronsPolyribosomesRibonucleasesRNA-Binding ProteinsRNA, MessengerSpinal CordSuperoxide DismutaseAntigens, SurfaceELAVL1 protein, humanELAV-Like Protein 1ELAV ProteinsRibonucleasesRNA-Binding ProteinsRNA, MessengerSOD1 protein, humanSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1TIAL1 protein, humanVascular Endothelial Growth Factor A

Identifiers

PMID19805546
PMCPMC2797169
OpenAlexW1985023569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.